Invus Financial Advisors, LLC
- SEC CIK
- 0001802978
- Latest filing
- Aug 14, 2024
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 8
- 0 vs. Q1 2022
- Portfolio value
- $165.6M
- −$59.1M (−26.3%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RCUSArcus Biosciences, Inc. | COM | 1,612,077 | $40.9M | 24.7% | 00.0% | Unchanged | History |
| CPNGCoupang, Inc. | CL A | 3,046,571 | $38.8M | 23.5% | 00.0% | Unchanged | History |
| NVCRNovoCure Ltd | ORD SHS | 350,884 | $24.4M | 14.7% | 00.0% | Unchanged | History |
| NUNu Holdings Ltd. | ORD SHS CL A | 5,582,950 | $20.9M | 12.6% | +5,582,950 | New | History |
| TBLATaboola.com Ltd. | ORD SHS | 7,819,690 | $19.8M | 11.9% | 00.0% | Unchanged | History |
| OYSTOyster Point Pharma, Inc. | COM | 2,768,586 | $12.0M | 7.2% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,007,575 | $4.51M | 2.7% | 00.0% | Unchanged | History |
| IONQIonQ, Inc. | COM | 1,000,000 | $4.38M | 2.6% | 00.0% | Unchanged | History |
Sold out since Q1 2022 (1)
Positions held at the end of Q1 2022 that are gone from this filing.